Medermycin : CDS list

ContigCDS IDstartstopdirproductgenekeywordcategory
AB103463Medem_000106511- ORF P  
AB103463Medem_000201181648- ORF Q  
AB103463Medem_0003019181211- ORF R  
AB103463Medem_0004037852091- ORF X  
AB103463Medem_0005047184149- ORF Y  
AB103463Medem_0006050005680+putative transcriptional regulatormed-ORF30 4.1 transcriptional regulator
AB103463Medem_0007063585738-hypothetical proteinmed-ORF26 5.4 hypothetical protein
AB103463Medem_0008079516374-putative drug resistance transportermed-ORF25 4.3 transport
AB103463Medem_0009089737948-putative oxidoreductasemed-ORF29 5.1 general function
AB103463Medem_0010090569697+putative TetR family transcriptional regulatormed-ORF28 4.1 transcriptional regulator
AB103463Medem_00110107859739-hypothetical proteinmed-ORF27 5.4 hypothetical protein
AB103463Medem_001201121111486+polyketide synthase acyl carrier protein subunitmed-ORF23type II PKS1.1 PKS
AB103463Medem_001301153612252+putative phosphopantetheinyl transferasemed-ORF24 1.4 Other
AB103463Medem_001401228713903+putative acyl-CoA carboxylase beta subunitmed-ORF22 5.1 general function
AB103463Medem_001501394214898+putative cyclase/dehydratasemed-ORF191st ring3.4 other modification
AB103463Medem_001601493616066+putative NDP-hexose C-3 aminotransferasemed-ORF20angolosamine2.3 modification addition of sugar moiety
AB103463Medem_001701606317127+putative glucose-1-phosphate thymidylyltransferase
putative dTDP-glucose synthase
med-ORF18 2.3 modification addition of sugar moiety
AB103463Medem_001801712418125+putative dTDP-glucose 4,6-dehydratasemed-ORF17 2.3 modification addition of sugar moiety
AB103463Medem_001901812219561+putative NDP-hexose 2,3-dehydratasemed-ORF16angolosamine2.3 modification addition of sugar moiety
AB103463Medem_002001961220334+putative NDP-hexose N,N-dimethyltransferasemed-ORF15angolosamine2.3 modification addition of sugar moiety
AB103463Medem_002102033121308+putative NDP-hexose C-4 ketoreductasemed-ORF14angolosamine2.3 modification addition of sugar moiety
AB103463Medem_002202135022366+putative phosphotransferasemed-ORF21 5.1 general function
AB103463Medem_002302292822425-putative NADH-dependent FMN reductasemed-ORF13two-component system
C-6 quinone formation
3.3 modification reduction
AB103463Medem_002402394622972-C-3 ketoreductasemed-ORF12S-stereochemistry3.3 modification reduction
AB103463Medem_002502412924905+putative transcriptional regulatormed-ORF11SARP family4.1 transcriptional regulator
AB103463Medem_002602491925359+hypothetical proteinmed-ORF10 5.4 hypothetical protein
AB103463Medem_002702540026419+putative oxidoreductasemed-ORF9 3.3 modification reduction
AB103463Medem_002802641627546+putative C-glycosyltransferasemed-ORF8 2.3 modification addition of sugar moiety
AB103463Medem_002902827227628-hypothetical proteinmed-ORF5 5.4 hypothetical protein
AB103463Medem_003002855629341+putative polyketide C-9 ketoreductasemed-ORF6 3.3 modification reduction
AB103463Medem_003102937530514+putative FMNH2-dependent monooxygenasemed-ORF7two-component system
C-6 quinone formation
3.3 modification reduction
AB103463Medem_003203065731925+polyketide synthase beta-ketoacyl synthase subunitmed-ORF1type II PKS1.1 PKS
AB103463Medem_003303192233148+polyketide synthase chain length factor subunitmed-ORF2type II PKS1.1 PKS
AB103463Medem_003403314134049+putative cyclase/dehydratasemed-ORF32nd ring3.4 other modification
AB103463Medem_003503537434145- med-ORF4  
AB103463Medem_003603620135704- ORF Z  
Page top